2023
Representativeness of Peripheral Artery Disease Randomized Clinical Trials Supporting Current Guidelines
Castro-Dominguez Y, Mena-Hurtado C, Algara M, Obas V, Ahmed Z, Romain G, Solaru K, Smolderen K. Representativeness of Peripheral Artery Disease Randomized Clinical Trials Supporting Current Guidelines. The American Journal Of Cardiology 2023, 201: 166-169. PMID: 37385170, DOI: 10.1016/j.amjcard.2023.05.053.Peer-Reviewed Original ResearchConceptsPeripheral artery diseasePAD guidelinesArtery diseaseRecent American Heart Association/American CollegeAmerican Heart Association/American CollegeLower extremity peripheral artery diseaseOlder adult patientsRace/ethnicity distributionAdult patientsPooled proportionMean ageClinical trialsCurrent guidelinesEpidemiologic studiesAmerican CollegeTrial participantsRCTsEthnicity distributionOlder adultsTrialsWomenPatientsDiseaseGuidelinesEthnic groups
2022
REPRESENTATIVENESS OF PERIPHERAL ARTERY DISEASE RANDOMIZED CLINICAL TRIALS SUPPORTING CURRENT GUIDELINE RECOMMENDATIONS
Dominguez Y, Hurtado C, Obas V, Algara M, Ahmed Z, Smolderen K. REPRESENTATIVENESS OF PERIPHERAL ARTERY DISEASE RANDOMIZED CLINICAL TRIALS SUPPORTING CURRENT GUIDELINE RECOMMENDATIONS. Journal Of The American College Of Cardiology 2022, 79: 1741. DOI: 10.1016/s0735-1097(22)02732-2.Peer-Reviewed Original Research
2019
TCT-555 The Association of Health-Related Quality-of-Life Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID Trial
Rymer J, Mulder H, Smolderen K, Hiatt W, Conte M, Berger J, Katona B, Norgren L, Mahaffey K, Rockhold F, Fowkes F, Jones S, Patel M. TCT-555 The Association of Health-Related Quality-of-Life Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID Trial. Journal Of The American College Of Cardiology 2019, 74: b547. DOI: 10.1016/j.jacc.2019.08.659.Peer-Reviewed Original Research
2010
Letter by Smolderen and Pelle Regarding Article, “Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial”
Smolderen KG, Pelle AJ. Letter by Smolderen and Pelle Regarding Article, “Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial”. Circulation 2010, 122: e445; author reply e446. PMID: 20805437, DOI: 10.1161/circulationaha.110.942086.Peer-Reviewed Original Research